Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers
Authors
Keywords
Ethyl Ester, Dose Proportionality, Therapeutic Lifestyle Change, Free Fatty Acid Form, Icosapent Ethyl
Journal
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
Volume 42, Issue 5, Pages 815-825
Publisher
Springer Nature
Online
2017-01-23
DOI
10.1007/s13318-016-0398-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study
- (2016) Janie Allaire et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
- (2016) Tarec K. Elajami et al. FASEB JOURNAL
- Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA
- (2015) Simon C. Dyall Frontiers in Aging Neuroscience
- Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
- (2014) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
- (2013) Matthew Spite et al. Cell Metabolism
- Omega-3 fatty acids
- (2013) Michael H. Davidson CURRENT OPINION IN LIPIDOLOGY
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
- (2012) Michael H. Davidson et al. Journal of Clinical Lipidology
- (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
- (2012) Dariush Mozaffarian et al. JOURNAL OF NUTRITION
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
- (2011) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Are all n-3 polyunsaturated fatty acids created equal?
- (2009) Breanne M Anderson et al. Lipids in Health and Disease
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started